Combined with the above findings, we hypothesized that eIF3a could relieve pulmonary hypertension in MCT-induced pulmonary hypertension rats by inhibiting EndMT, a process achieved by regulating the TGFβ1/SMAD signaling axis. The gene discussed is EIF3A; the disease is pulmonary hypertension.